Photo / Getty ImagesThere's growing interest in the use of psilocybin mushrooms in medicine. Photo / Getty ImagesA pharmaceutical company ­specialising in turning magic ­mushrooms into a treatment for severe depression is expanding clinical trials after signing a deal with an NHS trust and King's College London. The new partnership will speed up Compass Pathways' work in treatment areas such as post-traumatic stress disorder, anorexia and bipolar disorder. The substances in magic mushrooms have been used for hundreds of years and were rediscovered by Western medicine in the late 1950s. "She woke me up the next morning and said, 'you were alive in the Sixties and Seventies, what have you heard about magic mushrooms?'

Source: New Zealand Herald July 04, 2021 23:48 UTC